Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
 
© Copyright 1999-2017 DocMD.com. All Rights Reserved.